UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Chemotherapy for malignant gliomas

Journal of neurosurgery, 1988-01, Vol.68 (1), p.1-17

1988

Volltextzugriff (PDF)

Prediction of survival in glioma patients by means of positron emission tomography

Journal of neurosurgery, 1985-06, Vol.62 (6), p.816-822

1985

Volltextzugriff (PDF)

Basic fibroblast growth factor-like activity and receptors are expressed in a human glioma cell line

Cancer research (Chicago, Ill.), 1990-04, Vol.50 (8), p.2524-2529

1990

Volltextzugriff (PDF)

Basic fibroblast growth factor: A potential autocrine regulator of human glioma cell growth

Journal of neuroscience research, 1990-12, Vol.27 (4), p.689-696

1990

Volltextzugriff (PDF)

Anatomy of the Splanchnic Circulation

The Surgical clinics of North America, 1992-02, Vol.72 (1), p.1-30

1992

Volltextzugriff (PDF)

Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate

Cancer research (Chicago, Ill.), 1988-01, Vol.48 (2), p.291-296

1988

Volltextzugriff (PDF)

Interleukin-2 or autologous lymphokine-activated killer cell treatment of malignant glioma: phase I trial

Cancer research (Chicago, Ill.), 1986-04, Vol.46 (4), p.2101-2104

1986

Volltextzugriff (PDF)

Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain

Radiology, 1982-09, Vol.144 (4), p.885-889

1982

Volltextzugriff (PDF)

In vitro killing of human glioblastoma by interleukin-2-activated autologous lymphocytes

Journal of neurosurgery, 1986-01, Vol.64 (1), p.114-117

1986

Volltextzugriff (PDF)

Interleukin-2 and autologous lymphokine-activated killer cells in the treatment of malignant glioma. Preliminary report

Journal of neurosurgery, 1986-05, Vol.64 (5), p.743-749

1986

Volltextzugriff (PDF)

Lysis of intracranial hematomas with urokinase in a rabbit model

Journal of neurosurgery, 1985-04, Vol.62 (4), p.580-586

1985

Volltextzugriff (PDF)

Brain tumors and plasmin inhibitors

Neurosurgery, 1984-12, Vol.15 (6), p.795-800

1984

Volltextzugriff (PDF)

DNA cross-linking responses of human malignant glioma cell strains to chloroethylnitrosoureas, cisplatin, and diaziquone

Cancer research (Chicago, Ill.), 1987-08, Vol.47 (15), p.3988-3994

1987

Volltextzugriff (PDF)

Depressed cerebellar glucose metabolism in supratentorial tumors

Brain research, 1984-01, Vol.291 (1), p.93-101

1984

Volltextzugriff (PDF)

Effect of phorbol esters on the susceptibility of a glioma cell line to lymphokine-activated killer cell activity

Journal of neurosurgery, 1990-07, Vol.73 (1), p.91

1990

Volltextzugriff (PDF)

Products of cells cultured from gliomas. VI. Immunofluorescent, morphometric, and ultrastructural characterization of two different cell types growing from explants of human gliomas

The American journal of pathology, 1987-05, Vol.127 (2), p.358-372

1987

Volltextzugriff (PDF)

Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography

Neurology, 1982-12, Vol.32 (12), p.1323-1323

1982

Volltextzugriff (PDF)

Hepatocyte growth factor (HGF) and receptor (c-met) in normal and malignant astrocytic cells

Anticancer research, 1999-05, Vol.19 (3A), p.1635

1999

Volltextzugriff (PDF)

Radiation sensitivity of cultured human glioblastoma cells

Radiology, 1977-10, Vol.125 (1), p.231-234

1977

Volltextzugriff (PDF)

Corticotropin releasing factor administered into the ventricular CSF stimulates the pituitary-adrenal axis

Brain research, 1984-12, Vol.323 (2), p.365-368

1984

Volltextzugriff (PDF)

Glycolytic rate (PET) and contrast enhancement (CT) in human cerebral gliomas

American journal of neuroradiology : AJNR, 1983-05, Vol.4 (3), p.533-535

1983

Volltextzugriff (PDF)

In vitro studies on the cell-mediated immune response to human brain tumors. II. Leukocyte-induced coats of glycosaminoglycan increase the resistance of glioma cells to cellular immune attack

The Journal of immunology (1950), 1984-12, Vol.133 (6), p.3387-3395

1984

Volltextzugriff (PDF)

Positron emission tomographic study of suppression of gray-matter glucose utilization by brain tumors

American journal of neuroradiology : AJNR, 1983-05, Vol.4 (3), p.826-829

1983

Volltextzugriff (PDF)

Selective cytoplasmic and membrane changes induced by cisplatinum

Journal of neuro-oncology, 1990-12, Vol.9 (3), p.191-199

1990

Volltextzugriff (PDF)

Phase II and pharmacokinetic study of aziridinylbenzoquinone [2,5-diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone, diaziquone, NSC 182986] in high-grade gliomas

Cancer research (Chicago, Ill.), 1983-12, Vol.43 (12), p.6102-6105

1983

Volltextzugriff (PDF)

1 – 25 von 298

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(245)
Mit Volltextzugriff
(235)

Publikationsform

Sprache

Englisch
(294)
Japanisch
(3)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(149)
Biological And Medical Sciences
(144)
Medical Sciences
(137)
Science & Technology
(129)
Life Sciences & Biomedicine
(126)
Neurology
(72)
Tumors Of The Nervous System. Phacomatoses
(71)
Neurosciences & Neurology
(63)
Female
(53)
Male
(53)
Clinical Neurology
(52)
Middle Aged
(51)
Adult
(47)
Pharmacology. Drug Treatments
(45)
Surgery
(45)
Antineoplastic Agents
(40)
Oncology
(40)
Aged
(36)
Cell Line
(34)
Animals
(33)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Chemotherapy for malignant gliomas

Prediction of survival in glioma patients by means of positron emission tomography

Basic fibroblast growth factor-like activity and receptors are expressed in a human glioma cell line

Basic fibroblast growth factor: A potential autocrine regulator of human glioma cell growth

Anatomy of the Splanchnic Circulation

Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate

Interleukin-2 or autologous lymphokine-activated killer cell treatment of malignant glioma: phase I trial

Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain

In vitro killing of human glioblastoma by interleukin-2-activated autologous lymphocytes

Interleukin-2 and autologous lymphokine-activated killer cells in the treatment of malignant glioma. Preliminary report

Lysis of intracranial hematomas with urokinase in a rabbit model

Brain tumors and plasmin inhibitors

DNA cross-linking responses of human malignant glioma cell strains to chloroethylnitrosoureas, cisplatin, and diaziquone

Depressed cerebellar glucose metabolism in supratentorial tumors

Effect of phorbol esters on the susceptibility of a glioma cell line to lymphokine-activated killer cell activity

Products of cells cultured from gliomas. VI. Immunofluorescent, morphometric, and ultrastructural characterization of two different cell types growing from explants of human gliomas

Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography

Hepatocyte growth factor (HGF) and receptor (c-met) in normal and malignant astrocytic cells

Radiation sensitivity of cultured human glioblastoma cells

Corticotropin releasing factor administered into the ventricular CSF stimulates the pituitary-adrenal axis

Glycolytic rate (PET) and contrast enhancement (CT) in human cerebral gliomas

In vitro studies on the cell-mediated immune response to human brain tumors. II. Leukocyte-induced coats of glycosaminoglycan increase the resistance of glioma cells to cellular immune attack

Positron emission tomographic study of suppression of gray-matter glucose utilization by brain tumors

Selective cytoplasmic and membrane changes induced by cisplatinum

Phase II and pharmacokinetic study of aziridinylbenzoquinone [2,5-diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone, diaziquone, NSC 182986] in high-grade gliomas

Suchergebnisse filtern